Global Tumor Infiltrating Lymphocyte (TIL) Supply, Demand and Key Producers, 2024-2030
Page: 122
Published Date: 24 May 2024
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
Tumor-Infiltrating Lymphocytes (TILs) are a type of immune cell that has migrated from the bloodstream into a tumor or cancerous lesion. These lymphocytes, primarily T cells but also including other types such as B cells, natural killer (NK) cells, and dendritic cells, play a critical role in the body's immune response against cancer. TIL therapy has emerged as a promising cancer treatment strategy, particularly in the field of immunotherapy. This involves isolating TILs from a patient's tumor, growing them in large numbers in a laboratory, and then re-infusing them back into the patient after sometimes augmenting them to enhance their anti-tumor capabilities. The goal is to amplify the immune response against the cancer, leading to tumor regression.
The global Tumor Infiltrating Lymphocyte (TIL) market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).
This report studies the global Tumor Infiltrating Lymphocyte (TIL) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Tumor Infiltrating Lymphocyte (TIL), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tumor Infiltrating Lymphocyte (TIL) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Tumor Infiltrating Lymphocyte (TIL) total market, 2019-2030, (USD Million)
Global Tumor Infiltrating Lymphocyte (TIL) total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Tumor Infiltrating Lymphocyte (TIL) total market, key domestic companies, and share, (USD Million)
Global Tumor Infiltrating Lymphocyte (TIL) revenue by player, revenue and market share 2019-2024, (USD Million)
Global Tumor Infiltrating Lymphocyte (TIL) total market by Type, CAGR, 2019-2030, (USD Million)
Global Tumor Infiltrating Lymphocyte (TIL) total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Tumor Infiltrating Lymphocyte (TIL) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IOVANCE Biotherapeutics, Optera Therapeutics, TILT Biotherapeutics, KSQ Therapeutics, Lion TCR, Beijing Chineo, AbelZeta Inc, WuXi AppTec, Oricell Therapeutics, Guangzhou Biosyngen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Tumor Infiltrating Lymphocyte (TIL) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Tumor Infiltrating Lymphocyte (TIL) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Tumor Infiltrating Lymphocyte (TIL) Market, Segmentation by Type
T-cells
B-cells
Natural Killer Cells
Global Tumor Infiltrating Lymphocyte (TIL) Market, Segmentation by Application:
Melanoma
Colon Cancer
Cervical Cancer
Others
Companies Profiled:
IOVANCE Biotherapeutics
Optera Therapeutics
TILT Biotherapeutics
KSQ Therapeutics
Lion TCR
Beijing Chineo
AbelZeta Inc
WuXi AppTec
Oricell Therapeutics
Guangzhou Biosyngen
Shanghai Juncell Therapeutics
GRIT Biotechnology
Key Questions Answered
1. How big is the global Tumor Infiltrating Lymphocyte (TIL) market?
2. What is the demand of the global Tumor Infiltrating Lymphocyte (TIL) market?
3. What is the year over year growth of the global Tumor Infiltrating Lymphocyte (TIL) market?
4. What is the total value of the global Tumor Infiltrating Lymphocyte (TIL) market?
5. Who are the Major Players in the global Tumor Infiltrating Lymphocyte (TIL) market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 Tumor Infiltrating Lymphocyte (TIL) Introduction
1.2 World Tumor Infiltrating Lymphocyte (TIL) Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Tumor Infiltrating Lymphocyte (TIL) Total Market by Region (by Headquarter Location)
1.3.1 World Tumor Infiltrating Lymphocyte (TIL) Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Based Company Tumor Infiltrating Lymphocyte (TIL) Revenue (2019-2030)
1.3.3 China Based Company Tumor Infiltrating Lymphocyte (TIL) Revenue (2019-2030)
1.3.4 Europe Based Company Tumor Infiltrating Lymphocyte (TIL) Revenue (2019-2030)
1.3.5 Japan Based Company Tumor Infiltrating Lymphocyte (TIL) Revenue (2019-2030)
1.3.6 South Korea Based Company Tumor Infiltrating Lymphocyte (TIL) Revenue (2019-2030)
1.3.7 ASEAN Based Company Tumor Infiltrating Lymphocyte (TIL) Revenue (2019-2030)
1.3.8 India Based Company Tumor Infiltrating Lymphocyte (TIL) Revenue (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tumor Infiltrating Lymphocyte (TIL) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2.1 World Tumor Infiltrating Lymphocyte (TIL) Consumption Value (2019-2030)
2.2 World Tumor Infiltrating Lymphocyte (TIL) Consumption Value by Region
2.2.1 World Tumor Infiltrating Lymphocyte (TIL) Consumption Value by Region (2019-2024)
2.2.2 World Tumor Infiltrating Lymphocyte (TIL) Consumption Value Forecast by Region (2025-2030)
2.3 United States Tumor Infiltrating Lymphocyte (TIL) Consumption Value (2019-2030)
2.4 China Tumor Infiltrating Lymphocyte (TIL) Consumption Value (2019-2030)
2.5 Europe Tumor Infiltrating Lymphocyte (TIL) Consumption Value (2019-2030)
2.6 Japan Tumor Infiltrating Lymphocyte (TIL) Consumption Value (2019-2030)
2.7 South Korea Tumor Infiltrating Lymphocyte (TIL) Consumption Value (2019-2030)
2.8 ASEAN Tumor Infiltrating Lymphocyte (TIL) Consumption Value (2019-2030)
2.9 India Tumor Infiltrating Lymphocyte (TIL) Consumption Value (2019-2030)
3.1 World Tumor Infiltrating Lymphocyte (TIL) Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Tumor Infiltrating Lymphocyte (TIL) Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Tumor Infiltrating Lymphocyte (TIL) in 2023
3.2.3 Global Concentration Ratios (CR8) for Tumor Infiltrating Lymphocyte (TIL) in 2023
3.3 Tumor Infiltrating Lymphocyte (TIL) Company Evaluation Quadrant
3.4 Tumor Infiltrating Lymphocyte (TIL) Market: Overall Company Footprint Analysis
3.4.1 Tumor Infiltrating Lymphocyte (TIL) Market: Region Footprint
3.4.2 Tumor Infiltrating Lymphocyte (TIL) Market: Company Product Type Footprint
3.4.3 Tumor Infiltrating Lymphocyte (TIL) Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4.1 United States VS China: Tumor Infiltrating Lymphocyte (TIL) Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Tumor Infiltrating Lymphocyte (TIL) Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Tumor Infiltrating Lymphocyte (TIL) Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Tumor Infiltrating Lymphocyte (TIL) Consumption Value Comparison
4.2.1 United States VS China: Tumor Infiltrating Lymphocyte (TIL) Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Tumor Infiltrating Lymphocyte (TIL) Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Tumor Infiltrating Lymphocyte (TIL) Companies and Market Share, 2019-2024
4.3.1 United States Based Tumor Infiltrating Lymphocyte (TIL) Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Tumor Infiltrating Lymphocyte (TIL) Revenue, (2019-2024)
4.4 China Based Companies Tumor Infiltrating Lymphocyte (TIL) Revenue and Market Share, 2019-2024
4.4.1 China Based Tumor Infiltrating Lymphocyte (TIL) Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Tumor Infiltrating Lymphocyte (TIL) Revenue, (2019-2024)
4.5 Rest of World Based Tumor Infiltrating Lymphocyte (TIL) Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Tumor Infiltrating Lymphocyte (TIL) Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Tumor Infiltrating Lymphocyte (TIL) Revenue (2019-2024)
5.1 World Tumor Infiltrating Lymphocyte (TIL) Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 T-cells
5.2.2 B-cells
5.2.3 Natural Killer Cells
5.3 Market Segment by Type
5.3.1 World Tumor Infiltrating Lymphocyte (TIL) Market Size by Type (2019-2024)
5.3.2 World Tumor Infiltrating Lymphocyte (TIL) Market Size by Type (2025-2030)
5.3.3 World Tumor Infiltrating Lymphocyte (TIL) Market Size Market Share by Type (2025-2030)
6.1 World Tumor Infiltrating Lymphocyte (TIL) Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Melanoma
6.2.2 Colon Cancer
6.2.3 Cervical Cancer
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Tumor Infiltrating Lymphocyte (TIL) Market Size by Application (2019-2024)
6.3.2 World Tumor Infiltrating Lymphocyte (TIL) Market Size by Application (2025-2030)
6.3.3 World Tumor Infiltrating Lymphocyte (TIL) Market Size Market Share by Application (2019-2030)
7.1 IOVANCE Biotherapeutics
7.1.1 IOVANCE Biotherapeutics Details
7.1.2 IOVANCE Biotherapeutics Major Business
7.1.3 IOVANCE Biotherapeutics Tumor Infiltrating Lymphocyte (TIL) Product and Services
7.1.4 IOVANCE Biotherapeutics Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 IOVANCE Biotherapeutics Recent Developments/Updates
7.1.6 IOVANCE Biotherapeutics Competitive Strengths & Weaknesses
7.2 Optera Therapeutics
7.2.1 Optera Therapeutics Details
7.2.2 Optera Therapeutics Major Business
7.2.3 Optera Therapeutics Tumor Infiltrating Lymphocyte (TIL) Product and Services
7.2.4 Optera Therapeutics Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Optera Therapeutics Recent Developments/Updates
7.2.6 Optera Therapeutics Competitive Strengths & Weaknesses
7.3 TILT Biotherapeutics
7.3.1 TILT Biotherapeutics Details
7.3.2 TILT Biotherapeutics Major Business
7.3.3 TILT Biotherapeutics Tumor Infiltrating Lymphocyte (TIL) Product and Services
7.3.4 TILT Biotherapeutics Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 TILT Biotherapeutics Recent Developments/Updates
7.3.6 TILT Biotherapeutics Competitive Strengths & Weaknesses
7.4 KSQ Therapeutics
7.4.1 KSQ Therapeutics Details
7.4.2 KSQ Therapeutics Major Business
7.4.3 KSQ Therapeutics Tumor Infiltrating Lymphocyte (TIL) Product and Services
7.4.4 KSQ Therapeutics Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 KSQ Therapeutics Recent Developments/Updates
7.4.6 KSQ Therapeutics Competitive Strengths & Weaknesses
7.5 Lion TCR
7.5.1 Lion TCR Details
7.5.2 Lion TCR Major Business
7.5.3 Lion TCR Tumor Infiltrating Lymphocyte (TIL) Product and Services
7.5.4 Lion TCR Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Lion TCR Recent Developments/Updates
7.5.6 Lion TCR Competitive Strengths & Weaknesses
7.6 Beijing Chineo
7.6.1 Beijing Chineo Details
7.6.2 Beijing Chineo Major Business
7.6.3 Beijing Chineo Tumor Infiltrating Lymphocyte (TIL) Product and Services
7.6.4 Beijing Chineo Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Beijing Chineo Recent Developments/Updates
7.6.6 Beijing Chineo Competitive Strengths & Weaknesses
7.7 AbelZeta Inc
7.7.1 AbelZeta Inc Details
7.7.2 AbelZeta Inc Major Business
7.7.3 AbelZeta Inc Tumor Infiltrating Lymphocyte (TIL) Product and Services
7.7.4 AbelZeta Inc Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 AbelZeta Inc Recent Developments/Updates
7.7.6 AbelZeta Inc Competitive Strengths & Weaknesses
7.8 WuXi AppTec
7.8.1 WuXi AppTec Details
7.8.2 WuXi AppTec Major Business
7.8.3 WuXi AppTec Tumor Infiltrating Lymphocyte (TIL) Product and Services
7.8.4 WuXi AppTec Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 WuXi AppTec Recent Developments/Updates
7.8.6 WuXi AppTec Competitive Strengths & Weaknesses
7.9 Oricell Therapeutics
7.9.1 Oricell Therapeutics Details
7.9.2 Oricell Therapeutics Major Business
7.9.3 Oricell Therapeutics Tumor Infiltrating Lymphocyte (TIL) Product and Services
7.9.4 Oricell Therapeutics Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Oricell Therapeutics Recent Developments/Updates
7.9.6 Oricell Therapeutics Competitive Strengths & Weaknesses
7.10 Guangzhou Biosyngen
7.10.1 Guangzhou Biosyngen Details
7.10.2 Guangzhou Biosyngen Major Business
7.10.3 Guangzhou Biosyngen Tumor Infiltrating Lymphocyte (TIL) Product and Services
7.10.4 Guangzhou Biosyngen Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Guangzhou Biosyngen Recent Developments/Updates
7.10.6 Guangzhou Biosyngen Competitive Strengths & Weaknesses
7.11 Shanghai Juncell Therapeutics
7.11.1 Shanghai Juncell Therapeutics Details
7.11.2 Shanghai Juncell Therapeutics Major Business
7.11.3 Shanghai Juncell Therapeutics Tumor Infiltrating Lymphocyte (TIL) Product and Services
7.11.4 Shanghai Juncell Therapeutics Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Shanghai Juncell Therapeutics Recent Developments/Updates
7.11.6 Shanghai Juncell Therapeutics Competitive Strengths & Weaknesses
7.12 GRIT Biotechnology
7.12.1 GRIT Biotechnology Details
7.12.2 GRIT Biotechnology Major Business
7.12.3 GRIT Biotechnology Tumor Infiltrating Lymphocyte (TIL) Product and Services
7.12.4 GRIT Biotechnology Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 GRIT Biotechnology Recent Developments/Updates
7.12.6 GRIT Biotechnology Competitive Strengths & Weaknesses
8.1 Tumor Infiltrating Lymphocyte (TIL) Industry Chain
8.2 Tumor Infiltrating Lymphocyte (TIL) Upstream Analysis
8.3 Tumor Infiltrating Lymphocyte (TIL) Midstream Analysis
8.4 Tumor Infiltrating Lymphocyte (TIL) Downstream Analysis
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Tumor Infiltrating Lymphocyte (TIL) Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Tumor Infiltrating Lymphocyte (TIL) Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Tumor Infiltrating Lymphocyte (TIL) Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Tumor Infiltrating Lymphocyte (TIL) Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Tumor Infiltrating Lymphocyte (TIL) Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Tumor Infiltrating Lymphocyte (TIL) Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Tumor Infiltrating Lymphocyte (TIL) Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Tumor Infiltrating Lymphocyte (TIL) Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Tumor Infiltrating Lymphocyte (TIL) Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Tumor Infiltrating Lymphocyte (TIL) Players in 2023
Table 12. World Tumor Infiltrating Lymphocyte (TIL) Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Tumor Infiltrating Lymphocyte (TIL) Company Evaluation Quadrant
Table 14. Head Office of Key Tumor Infiltrating Lymphocyte (TIL) Players
Table 15. Tumor Infiltrating Lymphocyte (TIL) Market: Company Product Type Footprint
Table 16. Tumor Infiltrating Lymphocyte (TIL) Market: Company Product Application Footprint
Table 17. Tumor Infiltrating Lymphocyte (TIL) Mergers & Acquisitions Activity
Table 18. United States VS China Tumor Infiltrating Lymphocyte (TIL) Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Tumor Infiltrating Lymphocyte (TIL) Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Tumor Infiltrating Lymphocyte (TIL) Companies, Headquarters (States, Country)
Table 21. United States Based Companies Tumor Infiltrating Lymphocyte (TIL) Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Tumor Infiltrating Lymphocyte (TIL) Revenue Market Share (2019-2024)
Table 23. China Based Tumor Infiltrating Lymphocyte (TIL) Companies, Headquarters (Province, Country)
Table 24. China Based Companies Tumor Infiltrating Lymphocyte (TIL) Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Tumor Infiltrating Lymphocyte (TIL) Revenue Market Share (2019-2024)
Table 26. Rest of World Based Tumor Infiltrating Lymphocyte (TIL) Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Tumor Infiltrating Lymphocyte (TIL) Revenue (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Tumor Infiltrating Lymphocyte (TIL) Revenue Market Share (2019-2024)
Table 29. World Tumor Infiltrating Lymphocyte (TIL) Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Tumor Infiltrating Lymphocyte (TIL) Market Size Value by Type (2019-2024) & (USD Million)
Table 31. World Tumor Infiltrating Lymphocyte (TIL) Market Size by Type (2025-2030) & (USD Million)
Table 32. World Tumor Infiltrating Lymphocyte (TIL) Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Tumor Infiltrating Lymphocyte (TIL) Market Size by Application (2019-2024) & (USD Million)
Table 34. World Tumor Infiltrating Lymphocyte (TIL) Market Size by Application (2025-2030) & (USD Million)
Table 35. IOVANCE Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 36. IOVANCE Biotherapeutics Major Business
Table 37. IOVANCE Biotherapeutics Tumor Infiltrating Lymphocyte (TIL) Product and Services
Table 38. IOVANCE Biotherapeutics Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. IOVANCE Biotherapeutics Recent Developments/Updates
Table 40. IOVANCE Biotherapeutics Competitive Strengths & Weaknesses
Table 41. Optera Therapeutics Basic Information, Manufacturing Base and Competitors
Table 42. Optera Therapeutics Major Business
Table 43. Optera Therapeutics Tumor Infiltrating Lymphocyte (TIL) Product and Services
Table 44. Optera Therapeutics Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Optera Therapeutics Recent Developments/Updates
Table 46. Optera Therapeutics Competitive Strengths & Weaknesses
Table 47. TILT Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 48. TILT Biotherapeutics Major Business
Table 49. TILT Biotherapeutics Tumor Infiltrating Lymphocyte (TIL) Product and Services
Table 50. TILT Biotherapeutics Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. TILT Biotherapeutics Recent Developments/Updates
Table 52. TILT Biotherapeutics Competitive Strengths & Weaknesses
Table 53. KSQ Therapeutics Basic Information, Manufacturing Base and Competitors
Table 54. KSQ Therapeutics Major Business
Table 55. KSQ Therapeutics Tumor Infiltrating Lymphocyte (TIL) Product and Services
Table 56. KSQ Therapeutics Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. KSQ Therapeutics Recent Developments/Updates
Table 58. KSQ Therapeutics Competitive Strengths & Weaknesses
Table 59. Lion TCR Basic Information, Manufacturing Base and Competitors
Table 60. Lion TCR Major Business
Table 61. Lion TCR Tumor Infiltrating Lymphocyte (TIL) Product and Services
Table 62. Lion TCR Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Lion TCR Recent Developments/Updates
Table 64. Lion TCR Competitive Strengths & Weaknesses
Table 65. Beijing Chineo Basic Information, Manufacturing Base and Competitors
Table 66. Beijing Chineo Major Business
Table 67. Beijing Chineo Tumor Infiltrating Lymphocyte (TIL) Product and Services
Table 68. Beijing Chineo Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Beijing Chineo Recent Developments/Updates
Table 70. Beijing Chineo Competitive Strengths & Weaknesses
Table 71. AbelZeta Inc Basic Information, Manufacturing Base and Competitors
Table 72. AbelZeta Inc Major Business
Table 73. AbelZeta Inc Tumor Infiltrating Lymphocyte (TIL) Product and Services
Table 74. AbelZeta Inc Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. AbelZeta Inc Recent Developments/Updates
Table 76. AbelZeta Inc Competitive Strengths & Weaknesses
Table 77. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 78. WuXi AppTec Major Business
Table 79. WuXi AppTec Tumor Infiltrating Lymphocyte (TIL) Product and Services
Table 80. WuXi AppTec Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. WuXi AppTec Recent Developments/Updates
Table 82. WuXi AppTec Competitive Strengths & Weaknesses
Table 83. Oricell Therapeutics Basic Information, Manufacturing Base and Competitors
Table 84. Oricell Therapeutics Major Business
Table 85. Oricell Therapeutics Tumor Infiltrating Lymphocyte (TIL) Product and Services
Table 86. Oricell Therapeutics Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Oricell Therapeutics Recent Developments/Updates
Table 88. Oricell Therapeutics Competitive Strengths & Weaknesses
Table 89. Guangzhou Biosyngen Basic Information, Manufacturing Base and Competitors
Table 90. Guangzhou Biosyngen Major Business
Table 91. Guangzhou Biosyngen Tumor Infiltrating Lymphocyte (TIL) Product and Services
Table 92. Guangzhou Biosyngen Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Guangzhou Biosyngen Recent Developments/Updates
Table 94. Guangzhou Biosyngen Competitive Strengths & Weaknesses
Table 95. Shanghai Juncell Therapeutics Basic Information, Manufacturing Base and Competitors
Table 96. Shanghai Juncell Therapeutics Major Business
Table 97. Shanghai Juncell Therapeutics Tumor Infiltrating Lymphocyte (TIL) Product and Services
Table 98. Shanghai Juncell Therapeutics Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. Shanghai Juncell Therapeutics Recent Developments/Updates
Table 100. Shanghai Juncell Therapeutics Competitive Strengths & Weaknesses
Table 101. GRIT Biotechnology Basic Information, Manufacturing Base and Competitors
Table 102. GRIT Biotechnology Major Business
Table 103. GRIT Biotechnology Tumor Infiltrating Lymphocyte (TIL) Product and Services
Table 104. GRIT Biotechnology Tumor Infiltrating Lymphocyte (TIL) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. GRIT Biotechnology Recent Developments/Updates
Table 106. GRIT Biotechnology Competitive Strengths & Weaknesses
Table 107. Global Key Players of Tumor Infiltrating Lymphocyte (TIL) Upstream (Raw Materials)
Table 108. Global Tumor Infiltrating Lymphocyte (TIL) Typical Customers
List of Figures
Figure 1. Tumor Infiltrating Lymphocyte (TIL) Picture
Figure 2. World Tumor Infiltrating Lymphocyte (TIL) Total Revenue: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Tumor Infiltrating Lymphocyte (TIL) Total Revenue (2019-2030) & (USD Million)
Figure 4. World Tumor Infiltrating Lymphocyte (TIL) Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Figure 5. World Tumor Infiltrating Lymphocyte (TIL) Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Tumor Infiltrating Lymphocyte (TIL) Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Tumor Infiltrating Lymphocyte (TIL) Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Tumor Infiltrating Lymphocyte (TIL) Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Tumor Infiltrating Lymphocyte (TIL) Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Tumor Infiltrating Lymphocyte (TIL) Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Tumor Infiltrating Lymphocyte (TIL) Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Tumor Infiltrating Lymphocyte (TIL) Revenue (2019-2030) & (USD Million)
Figure 13. Tumor Infiltrating Lymphocyte (TIL) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Tumor Infiltrating Lymphocyte (TIL) Consumption Value (2019-2030) & (USD Million)
Figure 16. World Tumor Infiltrating Lymphocyte (TIL) Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Tumor Infiltrating Lymphocyte (TIL) Consumption Value (2019-2030) & (USD Million)
Figure 18. China Tumor Infiltrating Lymphocyte (TIL) Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Tumor Infiltrating Lymphocyte (TIL) Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Tumor Infiltrating Lymphocyte (TIL) Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Tumor Infiltrating Lymphocyte (TIL) Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Tumor Infiltrating Lymphocyte (TIL) Consumption Value (2019-2030) & (USD Million)
Figure 23. India Tumor Infiltrating Lymphocyte (TIL) Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Tumor Infiltrating Lymphocyte (TIL) by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Tumor Infiltrating Lymphocyte (TIL) Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Tumor Infiltrating Lymphocyte (TIL) Markets in 2023
Figure 27. United States VS China: Tumor Infiltrating Lymphocyte (TIL) Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Tumor Infiltrating Lymphocyte (TIL) Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Tumor Infiltrating Lymphocyte (TIL) Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Tumor Infiltrating Lymphocyte (TIL) Market Size Market Share by Type in 2023
Figure 31. T-cells
Figure 32. B-cells
Figure 33. Natural Killer Cells
Figure 34. World Tumor Infiltrating Lymphocyte (TIL) Market Size Market Share by Type (2019-2030)
Figure 35. World Tumor Infiltrating Lymphocyte (TIL) Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 36. World Tumor Infiltrating Lymphocyte (TIL) Market Size Market Share by Application in 2023
Figure 37. Melanoma
Figure 38. Colon Cancer
Figure 39. Cervical Cancer
Figure 40. Others
Figure 41. World Tumor Infiltrating Lymphocyte (TIL) Market Size Market Share by Application (2019-2030)
Figure 42. Tumor Infiltrating Lymphocyte (TIL) Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
IOVANCE Biotherapeutics Optera Therapeutics TILT Biotherapeutics KSQ Therapeutics Lion TCR Beijing Chineo AbelZeta Inc WuXi AppTec Oricell Therapeutics Guangzhou Biosyngen Shanghai Juncell Therapeutics GRIT Biotechnology
Related Reports
30 Jan 2023
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
